CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Endoscopes
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Endoscopic Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Transforaminal Endoscopic Procedures
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Interlaminar Endoscopic Procedures
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Endoscopic Posterior Foraminotomy and Cervical Discectomy
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Endoscopic Visualized Rhizotomy
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
CHAPTER 6: ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
CHAPTER 7: ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Procedure type
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product Type
7.2.5.1.3 Market size and forecast, by Procedure type
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product Type
7.2.5.2.3 Market size and forecast, by Procedure type
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product Type
7.2.5.3.3 Market size and forecast, by Procedure type
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Procedure type
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product Type
7.3.5.1.3 Market size and forecast, by Procedure type
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product Type
7.3.5.2.3 Market size and forecast, by Procedure type
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product Type
7.3.5.3.3 Market size and forecast, by Procedure type
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product Type
7.3.5.4.3 Market size and forecast, by Procedure type
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product Type
7.3.5.5.3 Market size and forecast, by Procedure type
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product Type
7.3.5.6.3 Market size and forecast, by Procedure type
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Procedure type
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product Type
7.4.5.1.3 Market size and forecast, by Procedure type
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product Type
7.4.5.2.3 Market size and forecast, by Procedure type
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product Type
7.4.5.3.3 Market size and forecast, by Procedure type
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product Type
7.4.5.4.3 Market size and forecast, by Procedure type
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product Type
7.4.5.5.3 Market size and forecast, by Procedure type
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product Type
7.4.5.6.3 Market size and forecast, by Procedure type
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Procedure type
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product Type
7.5.5.1.3 Market size and forecast, by Procedure type
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product Type
7.5.5.2.3 Market size and forecast, by Procedure type
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product Type
7.5.5.3.3 Market size and forecast, by Procedure type
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product Type
7.5.5.4.3 Market size and forecast, by Procedure type
7.5.5.4.4 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 MEDTRONIC PLC.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 MEDICALTEK CO., LTD.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 STRYKER CORPORATION
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 ZIMMER BIOMET HOLDINGS, INC.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 OLYMPUS CORPORATION
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 KARL STORZ SE & CO. KG
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Richard Wolf GmbH
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 GLOBUS MEDICAL INC.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Endovision Co., Ltd.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 joimax GmbH
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
TABLE 1. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC DEVICES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 7. ENDOSCOPIC SPINAL SURGERY MARKET FOR TRANSFORAMINAL ENDOSCOPIC PROCEDURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. ENDOSCOPIC SPINAL SURGERY MARKET FOR TRANSFORAMINAL ENDOSCOPIC PROCEDURES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. ENDOSCOPIC SPINAL SURGERY MARKET FOR INTERLAMINAR ENDOSCOPIC PROCEDURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. ENDOSCOPIC SPINAL SURGERY MARKET FOR INTERLAMINAR ENDOSCOPIC PROCEDURES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 13. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC VISUALIZED RHIZOTOMY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 14. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC VISUALIZED RHIZOTOMY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 15. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 16. ENDOSCOPIC SPINAL SURGERY MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. ENDOSCOPIC SPINAL SURGERY MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. ENDOSCOPIC SPINAL SURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. ENDOSCOPIC SPINAL SURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 20. ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 23. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 24. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 26. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 29. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 36. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 37. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 38. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 39. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 41. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 42. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 44. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 45. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 47. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 48. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 50. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 51. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 52. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 53. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 54. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 55. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 58. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 59. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 60. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 61. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 63. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 64. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 66. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 67. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 69. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 70. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 72. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 73. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 75. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 76. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 77. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 78. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 79. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 80. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 81. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 82. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 83. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 89. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 92. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 93. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 94.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): COMPANY SNAPSHOT
TABLE 95.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): OPERATING SEGMENTS
TABLE 96.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): PRODUCT PORTFOLIO
TABLE 97.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): NET SALES
TABLE 98.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): KEY STRATERGIES
TABLE 99.MEDTRONIC PLC.: COMPANY SNAPSHOT
TABLE 100.MEDTRONIC PLC.: OPERATING SEGMENTS
TABLE 101.MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 102.MEDTRONIC PLC.: NET SALES
TABLE 103.MEDTRONIC PLC.: KEY STRATERGIES
TABLE 104.MEDICALTEK CO., LTD.: COMPANY SNAPSHOT
TABLE 105.MEDICALTEK CO., LTD.: OPERATING SEGMENTS
TABLE 106.MEDICALTEK CO., LTD.: PRODUCT PORTFOLIO
TABLE 107.MEDICALTEK CO., LTD.: NET SALES
TABLE 108.MEDICALTEK CO., LTD.: KEY STRATERGIES
TABLE 109.STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 110.STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 111.STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 112.STRYKER CORPORATION: NET SALES
TABLE 113.STRYKER CORPORATION: KEY STRATERGIES
TABLE 114.ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 115.ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 116.ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 117.ZIMMER BIOMET HOLDINGS, INC.: NET SALES
TABLE 118.ZIMMER BIOMET HOLDINGS, INC.: KEY STRATERGIES
TABLE 119.OLYMPUS CORPORATION: COMPANY SNAPSHOT
TABLE 120.OLYMPUS CORPORATION: OPERATING SEGMENTS
TABLE 121.OLYMPUS CORPORATION: PRODUCT PORTFOLIO
TABLE 122.OLYMPUS CORPORATION: NET SALES
TABLE 123.OLYMPUS CORPORATION: KEY STRATERGIES
TABLE 124.KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
TABLE 125.KARL STORZ SE & CO. KG: OPERATING SEGMENTS
TABLE 126.KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
TABLE 127.KARL STORZ SE & CO. KG: NET SALES
TABLE 128.KARL STORZ SE & CO. KG: KEY STRATERGIES
TABLE 129.RICHARD WOLF GMBH: COMPANY SNAPSHOT
TABLE 130.RICHARD WOLF GMBH: OPERATING SEGMENTS
TABLE 131.RICHARD WOLF GMBH: PRODUCT PORTFOLIO
TABLE 132.RICHARD WOLF GMBH: NET SALES
TABLE 133.RICHARD WOLF GMBH: KEY STRATERGIES
TABLE 134.GLOBUS MEDICAL INC.: COMPANY SNAPSHOT
TABLE 135.GLOBUS MEDICAL INC.: OPERATING SEGMENTS
TABLE 136.GLOBUS MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 137.GLOBUS MEDICAL INC.: NET SALES
TABLE 138.GLOBUS MEDICAL INC.: KEY STRATERGIES
TABLE 139.ENDOVISION CO., LTD.: COMPANY SNAPSHOT
TABLE 140.ENDOVISION CO., LTD.: OPERATING SEGMENTS
TABLE 141.ENDOVISION CO., LTD.: PRODUCT PORTFOLIO
TABLE 142.ENDOVISION CO., LTD.: NET SALES
TABLE 143.ENDOVISION CO., LTD.: KEY STRATERGIES
TABLE 144.JOIMAX GMBH: COMPANY SNAPSHOT
TABLE 145.JOIMAX GMBH: OPERATING SEGMENTS
TABLE 146.JOIMAX GMBH: PRODUCT PORTFOLIO
TABLE 147.JOIMAX GMBH: NET SALES
TABLE 148.JOIMAX GMBH: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/